Knowledge (XXG)

Clodronic acid

Source 📝

347: 324: 1010: 29: 577:
Clodronic acid is approved for human use in Canada and Australia, the United Kingdom, where it is marketed as Bonefos, Loron, Clodron and in Italy as Clasteon, Difosfonal, Osteostab and several generics. In other countries is prescribed as a bone resorption inhibitor and antihypercalcemic agent. It
590:. It is given by intramuscular injection at one point in time, with the total dose divided into 2-3 sites on the horse. Clinical effects (e.g. improvement of lameness) after a single treatment can be seen up to 6 months post-treatment. 751: 635:
Pennanen N, Lapinjoki S, Urtti A, Mönkkönen J (June 1995). "Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro".
59: 744: 737: 41: 433: 419: 957: 492: 453: 678:
Rovetta G, Monteforte P, Balestra V (2000). "Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture".
121: 89: 567:
in osteoporotic vertebral fractures showed that clodronic acid provided more analgesia than 3 grams/day of acetaminophen.
1000: 862: 711: 707:"FDA Provides Equine Veterinarians with Important Information about TILDREN and OSPHOS for Navicular Syndrome in Horses" 586:
Clodronic acid is approved for use in horses under the trade name Osphos, for treatment of bone resorptive processes of
223: 1035: 552: 303: 543:
and fracture related pain because of its anti-inflammatory effects shown as a reduction in inflammatory markers like
854: 520: 1040: 1030: 895: 342: 292: 706: 615: 532: 319: 138: 905: 660: 587: 544: 272: 960: 687: 652: 103: 729: 1014: 644: 540: 359: 232: 212: 147: 867: 842: 822: 817: 812: 807: 802: 797: 792: 787: 51: 346: 323: 832: 774: 578:
is not approved for use in the United States, because it has too many adverse effects.
524: 1024: 965: 564: 548: 536: 335: 664: 970: 765: 761: 528: 72: 67: 172: 943: 935: 888: 603: 571: 527:. It is an anti-osteoporotic drug approved for the prevention and treatment of 20: 977: 950: 928: 648: 598:
Clodronic acid has been shown to have several adverse effects. These include:
395: 203: 987: 920: 570:
Clodronic acid is also used in experimental medicine to selectively deplete
45: 28: 691: 656: 782: 183: 192: 982: 158: 283: 252: 913: 461:
InChI=1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9)
418: 409: 263: 563:
A study comparing the analgesic effect of clodronic acid versus
531:
in post-menopausal women and men to reduce vertebral fractures,
243: 733: 308: 98: 478: 998: 876: 853: 773: 407: 394: 358: 353: 334: 302: 282: 262: 242: 222: 202: 182: 157: 137: 112: 88: 83: 58: 40: 35: 171: 146: 680:Drugs Under Experimental and Clinical Research 745: 8: 19: 752: 738: 730: 523:) is a first generation (non-nitrogenous) 345: 322: 211: 129:(Dichloro-phosphono-methyl)phosphonic acid 27: 231: 1005: 627: 458: 438: 318: 191: 126: 606:, usually within 2 hours of treatment. 336: 18: 291: 271: 50: 7: 71: 958:Parathyroid hormone-related protein 705:U.S. Food and Drug Administration. 602:Signs of discomfort, agitation, or 251: 162: 385: 14: 1008: 373: 367: 466:Key:ACSIXWWBWUQEHA-UHFFFAOYSA-N 379: 364: 1: 712:Food and Drug Administration 855:Bone morphogenetic proteins 441:ClC(Cl)(P(=O)(O)O)P(=O)(O)O 1057: 354:Chemical and physical data 474: 449: 429: 117: 26: 52:International Drug Names 896:Aluminium chlorohydrate 760:Drugs for treatment of 649:10.1023/A:1016281608773 637:Pharmaceutical Research 901:Dual action bone agent 884:Resorption inhibitor 533:hyperparathyroidism 497:clodronate disodium 23: 1036:Equine medications 906:Strontium ranelate 588:navicular syndrome 996: 995: 486: 485: 420:Interactive image 304:CompTox Dashboard 101: 16:Chemical compound 1048: 1013: 1012: 1011: 1004: 829:Non-nitrogenous 754: 747: 740: 731: 724: 723: 721: 719: 702: 696: 695: 675: 669: 668: 632: 541:multiple myeloma 482: 481: 422: 402: 387: 381: 375: 369: 366: 349: 338: 327: 326: 312: 310: 295: 275: 255: 235: 215: 195: 175: 165: 164: 150: 100: 97: 75: 54: 31: 24: 22: 1056: 1055: 1051: 1050: 1049: 1047: 1046: 1045: 1041:Organochlorides 1031:Bisphosphonates 1021: 1020: 1019: 1009: 1007: 999: 997: 992: 872: 868:Eptotermin alfa 863:Dibotermin alfa 849: 843:Tiludronic acid 823:Zoledronic acid 818:Risedronic acid 813:Pamidronic acid 808:Neridronic acid 803:Minodronic acid 798:Incadronic acid 793:Ibandronic acid 788:Alendronic acid 775:Bisphosphonates 769: 758: 728: 727: 717: 715: 704: 703: 699: 677: 676: 672: 634: 633: 629: 624: 596: 594:Adverse effects 584: 582:Veterinary uses 561: 539:in malignancy, 518: 514: 510: 506: 502: 477: 475: 470: 467: 462: 457: 456: 445: 442: 437: 436: 425: 400: 390: 384: 378: 372: 330: 306: 298: 278: 258: 238: 218: 198: 178: 161: 153: 133: 130: 125: 124: 108: 79: 17: 12: 11: 5: 1054: 1052: 1044: 1043: 1038: 1033: 1023: 1022: 1018: 1017: 994: 993: 991: 990: 985: 980: 975: 974: 973: 968: 955: 954: 953: 940: 939: 938: 925: 924: 923: 910: 909: 908: 898: 893: 892: 891: 880: 878: 874: 873: 871: 870: 865: 859: 857: 851: 850: 848: 847: 846: 845: 840: 838:Clodronic acid 835: 833:Etidronic acid 827: 826: 825: 820: 815: 810: 805: 800: 795: 790: 779: 777: 771: 770: 759: 757: 756: 749: 742: 734: 726: 725: 697: 670: 626: 625: 623: 620: 619: 618: 613: 610: 607: 595: 592: 583: 580: 560: 557: 525:bisphosphonate 516: 512: 508: 504: 500: 489:Clodronic acid 484: 483: 472: 471: 469: 468: 465: 463: 460: 452: 451: 450: 447: 446: 444: 443: 440: 432: 431: 430: 427: 426: 424: 423: 415: 413: 405: 404: 398: 392: 391: 388: 382: 376: 370: 362: 356: 355: 351: 350: 340: 332: 331: 329: 328: 315: 313: 300: 299: 297: 296: 288: 286: 280: 279: 277: 276: 268: 266: 260: 259: 257: 256: 248: 246: 240: 239: 237: 236: 228: 226: 220: 219: 217: 216: 208: 206: 200: 199: 197: 196: 188: 186: 180: 179: 177: 176: 168: 166: 155: 154: 152: 151: 143: 141: 135: 134: 132: 131: 128: 120: 119: 118: 115: 114: 110: 109: 107: 106: 94: 92: 86: 85: 81: 80: 78: 77: 64: 62: 56: 55: 48: 38: 37: 33: 32: 21:Clodronic acid 15: 13: 10: 9: 6: 4: 3: 2: 1053: 1042: 1039: 1037: 1034: 1032: 1029: 1028: 1026: 1016: 1006: 1002: 989: 986: 984: 981: 979: 976: 972: 969: 967: 966:Abaloparatide 964: 963: 962: 959: 956: 952: 949: 948: 947: 945: 941: 937: 934: 933: 932: 930: 926: 922: 919: 918: 917: 915: 911: 907: 904: 903: 902: 899: 897: 894: 890: 887: 886: 885: 882: 881: 879: 875: 869: 866: 864: 861: 860: 858: 856: 852: 844: 841: 839: 836: 834: 831: 830: 828: 824: 821: 819: 816: 814: 811: 809: 806: 804: 801: 799: 796: 794: 791: 789: 786: 785: 784: 781: 780: 778: 776: 772: 767: 763: 762:bone diseases 755: 750: 748: 743: 741: 736: 735: 732: 714: 713: 708: 701: 698: 693: 689: 685: 681: 674: 671: 666: 662: 658: 654: 650: 646: 643:(6): 916–22. 642: 638: 631: 628: 621: 617: 616:Renal failure 614: 611: 608: 605: 601: 600: 599: 593: 591: 589: 581: 579: 575: 573: 568: 566: 565:acetaminophen 558: 556: 554: 550: 546: 542: 538: 537:hypercalcemia 534: 530: 526: 522: 498: 494: 490: 480: 473: 464: 459: 455: 448: 439: 435: 428: 421: 417: 416: 414: 411: 406: 399: 397: 393: 363: 361: 357: 352: 348: 344: 341: 339: 337:ECHA InfoCard 333: 325: 321: 320:DTXSID8046959 317: 316: 314: 305: 301: 294: 290: 289: 287: 285: 281: 274: 270: 269: 267: 265: 261: 254: 250: 249: 247: 245: 241: 234: 230: 229: 227: 225: 221: 214: 210: 209: 207: 205: 201: 194: 190: 189: 187: 185: 181: 174: 170: 169: 167: 160: 156: 149: 145: 144: 142: 140: 136: 127: 123: 116: 111: 105: 96: 95: 93: 91: 87: 82: 74: 69: 66: 65: 63: 61: 57: 53: 49: 47: 43: 39: 36:Clinical data 34: 30: 25: 971:Teriparatide 942: 927: 912: 900: 883: 837: 716:. Retrieved 710: 700: 686:(1): 25–30. 683: 679: 673: 640: 636: 630: 609:Head shaking 597: 585: 576: 569: 562: 559:Medical uses 529:osteoporosis 496: 488: 487: 476:   273:CHEBI:110423 90:Legal status 84:Legal status 944:Cathepsin K 936:Romosozumab 889:Ipriflavone 783:Nitrogenous 612:Lip licking 572:macrophages 403: g·mol 343:100.031.090 293:ChEMBL12318 113:Identifiers 1025:Categories 978:Calcitonin 951:Odanacatib 929:Sclerostin 622:References 408:3D model ( 396:Molar mass 233:0813BZ6866 204:ChemSpider 148:10596-23-3 139:CAS Number 122:IUPAC name 1015:Chemistry 988:Vitamin D 961:analogues 946:inhibitor 931:inhibitor 921:Denosumab 916:inhibitor 718:3 January 46:Drugs.com 692:10761534 665:46332840 479:(verify) 184:DrugBank 60:ATC code 983:Calcium 657:7667201 360:Formula 193:DB00720 159:PubChem 102:: 76:) 70: ( 68:M05BA02 1001:Portal 690:  663:  655:  551:, and 434:SMILES 401:244.88 284:ChEMBL 253:D03545 104:℞-only 914:RANKL 877:Other 661:S2CID 604:colic 553:TNF-α 545:IL-1β 495:) or 454:InChI 410:JSmol 264:ChEBI 213:23731 173:25419 720:2015 688:PMID 653:PMID 549:IL-6 521:USAN 244:KEGG 224:UNII 42:AHFS 766:M05 645:doi 555:. 519:) ( 499:(Na 493:INN 309:EPA 163:CID 73:WHO 1027:: 709:. 684:26 682:. 659:. 651:. 641:12 639:. 574:. 547:, 535:, 507:Cl 503:CH 374:Cl 99:CA 1003:: 768:) 764:( 753:e 746:t 739:v 722:. 694:. 667:. 647:: 517:2 515:P 513:6 511:O 509:2 505:2 501:2 491:( 412:) 389:2 386:P 383:6 380:O 377:2 371:4 368:H 365:C 311:) 307:( 44:/

Index


AHFS
Drugs.com
International Drug Names
ATC code
M05BA02
WHO
Legal status
℞-only
IUPAC name
CAS Number
10596-23-3
PubChem
25419
DrugBank
DB00720
ChemSpider
23731
UNII
0813BZ6866
KEGG
D03545
ChEBI
CHEBI:110423
ChEMBL
ChEMBL12318
CompTox Dashboard
DTXSID8046959
Edit this at Wikidata
ECHA InfoCard

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.